Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Liver Transpl. 2021 Aug 20;27(11):1613–1622. doi: 10.1002/lt.26232

TABLE 1.

Baseline Demographics of the 572 Patients Undergoing SLKT

Characteristic Value
Age, years 57.7 (50.8-63.8)
Female sex 211 (37)
Race
 Caucasian 477 (83)
 African American 73 (13)
 Other 22 (4)
BMI, kg/m2 27.2 (23.5-32.2)
Year of transplantation
 2002-2006 164 (29)
 2007-2010 130 (23)
 2011-2014 178 (31)
 2015-2017 100 (17)
Indication for SLKT
 AKD 237 (41)
 CKD 303 (53)
 Indeterminate 32 (6)
Days with eGFR <60 mL/minute/1.73 m2 204 (60-672)
Days with eGFR <25 mL/minute/1.73 m2 67 (22-259)
Hemodialysis at listing 224 (39)
Days on hemodialysis before SLKT 13 (0-94)
Hepatitis C 188 (33)
EtOH related 132 (23)
NASH 110 (19)
Diabetes mellitus 239 (42)
Hypertension 303 (53)
Coronary artery disease 116 (20)
MELD at SLKT 30 (25-36)
Serum creatinine at SLKT (mg/dL) 3.0 (2.1-4.6)
Ascites
 None 138 (24)
 Mild 74 (13)
 Moderate 180 (31)
 Refractory 180 (31)
Hepatic encephalopathy 363 (63)
Hospitalization status
 Home 171 (30)
 Medical ward 76 (13)
 Intensive care unit 325 (57)
Mechanical ventilation 119 (21)
Hemodialysis at SLKT 212 (37)
Cold ischemia time (min) 360 (300-477)
Warm ischemia time (min) 38 (23-60)
Donor distance
 Local 522 (91)
 Regional 36 (6)
 National 14 (2)
Delayed graft function 131 (23)

NOTE: The data are expressed as median (IQR) or n (%).